DeepMed Research

INSTITUT CURIE

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1909-01-01

Employees: 1K

Market Cap: -

Website: http://www.curie.fr

Clinical Trials

First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years

Phase 2

Completed

Conditions: Ewing Sarcoma Family of Tumors

Interventions: Drug: VDC-IE x2
Drug: VDC-IE
Drug: TEMIRI
Drug: Consolidation BuMel
Drug: Maintenance
Radiation: Local treatment by radiotherapy
Procedure: Local treatment by surgery

First Posted Date: 2017-01-05

Last Posted Date: 2024-01-29

Lead Sponsor: Institut Curie

Target Recruit Count: 45

Registration Number: NCT03011528

Locations: 🇫🇷
Nantes Chu, Nantes, France
🇫🇷
Bordeaux Chu, Bordeaux, France
🇫🇷
Chr Felix Guyon, La Réunion, Saint Denis, France

and more 14 locations

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)

Not Applicable

Completed

Conditions: Choroidal Melanoma

Interventions: Biological: Blood sampling

First Posted Date: 2016-08-23

Last Posted Date: 2024-01-31

Lead Sponsor: Institut Curie

Target Recruit Count: 800

Registration Number: NCT02875652

Locations: 🇫🇷
Institut Curie, Paris, France

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Not Applicable

Active, not recruiting

Conditions: Melanoma, Uveal
Uveal Melanoma

Interventions: Procedure: Endoresection
Procedure: Laser diode

First Posted Date: 2016-08-22

Last Posted Date: 2023-12-01

Lead Sponsor: Institut Curie

Target Recruit Count: 87

Registration Number: NCT02874040

Locations: 🇫🇷
Institut Curie, Paris, France

Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Phase 2

Recruiting

Conditions: Retinoblastoma

Interventions: Radiation: Orbital irradiation
Other: Observation
Drug: Etoposide
Drug: Vincristine
Drug: Carboplatin
Drug: Cyclophosphamide
Drug: Thiotepa
Procedure: Cytapheresis
Procedure: Peripheral bood stem cell transplantation

First Posted Date: 2016-08-17

Last Posted Date: 2024-05-31

Lead Sponsor: Institut Curie

Target Recruit Count: 185

Registration Number: NCT02870907

Locations: 🇫🇷
Chr Felix Guyon, Saint-Denis, La Réunion, France
🇫🇷
Hopital Nord Chu Amiens, Amiens, France
🇫🇷
Chu Angers, Angers, France

and more 24 locations

Conservative Treatments of Retinoblastoma

Phase 2

Active, not recruiting

Conditions: Retinoblastoma
Retinal Neoplasm
Children

Interventions: Drug: VP16, carboplatin
Drug: VP16, carboplatin, vincristin
Drug: Melphalan
Drug: Carboplatin + laser day 1 (chemothermotherapy)
Device: Laser (local treatment)
Device: cryoapplication (local treatment)
Radiation: I125 radioactive plaques (local treatment)
Drug: intravitreal Melphalan (local treatment)

First Posted Date: 2016-08-15

Last Posted Date: 2024-01-31

Lead Sponsor: Institut Curie

Target Recruit Count: 133

Registration Number: NCT02866136

Locations: 🇫🇷
Institut Curie, Paris, France

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

Not Applicable

Completed

Conditions: Cancer

Interventions: Biological: Blood sampling
Procedure: Tumor sampling
Other: Stool sampling

First Posted Date: 2016-08-15

Last Posted Date: 2024-09-30

Lead Sponsor: Institut Curie

Target Recruit Count: 682

Registration Number: NCT02866149

Locations: 🇫🇷
Institut Curie (Paris hospital), Paris, France
🇫🇷
Centre Georges François Leclerc, Dijon, France
🇫🇷
Institut du Cancer de Montpellier, Montpellier, France

and more 2 locations

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

Not Applicable

Completed

Conditions: Neuroblastoma

Interventions: Procedure: Blood sampling

First Posted Date: 2016-08-12

Last Posted Date: 2023-12-01

Lead Sponsor: Institut Curie

Target Recruit Count: 560

Registration Number: NCT02864563

Locations: 🇫🇷
CHU MORVAN Brest, Brest, France
🇫🇷
Hôpital Nord Amiens, Amiens, France
🇫🇷
Chu Angers, Angers, France

and more 24 locations

FSH-R : Diagnostic Application for Localized Tumors in Cancerology

Not Applicable

Terminated

Conditions: Cancer

Interventions: Procedure: blood sample for FSHR analysis

First Posted Date: 2016-08-09

Last Posted Date: 2023-08-24

Lead Sponsor: Institut Curie

Target Recruit Count: 95

Registration Number: NCT02860481

Locations: 🇫🇷
Centre René Huguenin, Saint Cloud, France
🇫🇷
Institut Curie, Paris, France

Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.

Conditions: Quality of Life
Solid Tumors

First Posted Date: 2016-08-05

Last Posted Date: 2016-08-05

Lead Sponsor: Institut Curie

Target Recruit Count: 250

Registration Number: NCT02857699

Locations: 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷
Institut Curie, Paris, France
🇫🇷
Centre Claudius Regaud, Toulouse, France

Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation

Completed

Conditions: Metastatic Cancer
Palliative Care

Interventions: Other: Booklet-Question List

First Posted Date: 2016-08-03

Last Posted Date: 2016-08-03

Lead Sponsor: Institut Curie

Target Recruit Count: 121

Registration Number: NCT02854293

Locations: 🇫🇷
Centre Alexis Vautrin, Nancy, France
🇫🇷
Léon Berard, Lyon, France
🇫🇷
Hopital René Huguenin, Saint Cloud, France

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy